Innovation Spotlight: Quantgene: Direct-to-Consumer Genetic Testing

Report Code: HLC270A


November 2020

"Are my ancestors from Ireland?" is trending towards "What is my risk for colorectal cancer?" DTC genetic testing has evolved over the past ten years, from exploring ancestry toward consumers wanting to know their risks of disorders such as cancers.

DTC genetic testing analyzes a person's genome, which helps to know about ancestry inference, disease risks, and other personal traits.

BCC interviewed Quantgene, a company working to unlock the Deep Human Genome by building the world’s leading Deep Genomics solution. Their mission is to save lives through early detection, better prevention, and more effective cures for cancer.

Continue reading this report plus more!

Monthly Access $9.99

  • Access to our Library of published and upcoming Innovation Spotlights
  • Access to thousands of select free reports from publishers such as Barnes Reports, TBRC, Verified Market Research, & Primary Research Group
  • Exclusive discounts on full length reports from BCC Research & various additional publishers
  • Cancel at anytime

Single Paper $59.99

  • One Time Purchase
  • Downloadable PDF